Urapidil Hydrochloride Injection GMP Approved

• Certificate: ISO GMP
• Transport Package: Carton
• Specification: 10ml: 50mg 5ml: 25mg
• Trademark: SHIMEN
• Origin: Hebei
• Model NO.: 10ml: 50mg 5ml: 25mg

Product Description

Urapidil Hydrochloride Injection
 

Product Name: Urapidil Hydrochloride Injection
Usage and Dosage:
1. Treatment of hypertensive crisis, severe and very severe hypertension, and refractory hypertension
1) Intravenous injection
Slowly inject 10-50 mg of uradil intravenously and monitor the change of blood pressure, the effect of lowering blood pressure is usually shown within 5 minutes. If the effect is not satisfactory, the drug may be repeated.
2)Continuous intravenous drip or use of infusion pumps
To maintain the antihypertensive effect of this product after intravenous injection, it may be given by continuous intravenous drip.
The product can be administered intravenously as a single injection, repeated intravenous injections or for a prolonged period of time, and can also be administered intravenously continuously after intravenous injection in order to maintain the stability of blood pressure. Patients should be placed in the prone position during intravenous administration. Toxicologically, the duration of treatment should not exceed 7 days.

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.

For the key product of large volume I.V solution, the yearly output has reached more than 1.5 billion bottles including 1 billion packing with the soft plastic bottles and plastic bags in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.  The products have been sold to some countries and regions in South America, Africa, and Asia.